MN Stat § 152.28 (2021)
2021 Minnesota Statutes|Chapters 144 - 159 — Health|Chapter 152 — Drugs; Controlled Substances|Section 152.28 — Health Care Practitioner Duties.

152.28 HEALTH CARE PRACTITIONER DUTIES. Subdivision 1. Health care practitioner duties. (a) Prior to a patient's enrollment in the registry program, a health care practitioner shall: (1) determine, in the health care practitioner's medical judgment, whether a patient suffers from a qualifying medical condition, and, if so determined, provide the patient with a certification of that diagnosis; (2) advise patients, registered designated caregivers, and parents, legal guardians, or spouses who are acting as caregivers of the existence of any nonprofit patient support groups or organizations; (3) provide explanatory information from the commissioner to patients with qualifying medical conditions, including disclosure to all patients about the experimental nature of therapeutic use of medical cannabis; the possible risks, benefits, and side effects of the proposed treatment; the application and other materials from the commissioner; and provide patients with the Tennessen warning as required by section 13.04, subdivision 2; and (4) agree to continue treatment of the patient's qualifying medical condition and report medical findings to the commissioner. (b) Upon notification from the commissioner of the patient's enrollment in the registry program, the health care practitioner shall: (1) participate in the patient registry reporting system under the guidance and supervision of the commissioner; (2) report health records of the patient throughout the ongoing treatment of the patient to the commissioner in a manner determined by the commissioner and in accordance with subdivision 2; (3) determine, on a yearly basis, if the patient continues to suffer from a qualifying medical condition and, if so, issue the patient a new certification of that diagnosis; and (4) otherwise comply with all requirements developed by the commissioner. (c) A health care practitioner may conduct a patient assessment to issue a recertification as required under paragraph (b), clause (3), via telehealth, as defined in section 62A.673, subdivision 2. (d) Nothing in this section requires a health care practitioner to participate in the registry program. Subd. 2. Data. Data collected on patients by a health care practitioner and reported to the patient registry are health records under section 144.291, and are private data on individuals under section 13.02, but may be used or reported in an aggregated, nonidentifiable form as part of a scientific, peer-reviewed publication of research conducted under section 152.25 or in the creation of summary data, as defined in section 13.02, subdivision 19. Subd. 3. Advertising restrictions. (a) A health care practitioner shall not publish or cause to be published any advertisement that: (1) contains false or misleading statements about medical cannabis or about the medical cannabis registry program; (2) uses colloquial terms to refer to medical cannabis, such as pot, weed, or grass; (3) states or implies the health care practitioner is endorsed by the Department of Health or by the medical cannabis registry program; (4) includes images of cannabis in its plant or leaf form or of cannabis-smoking paraphernalia; or (5) contains medical symbols that could reasonably be confused with symbols of established medical associations or groups. (b) A health care practitioner found by the commissioner to have violated this subdivision is prohibited from certifying that patients have a qualifying medical condition for purposes of patient participation in the registry program. The commissioner's decision that a health care practitioner has violated this subdivision is a final decision of the commissioner and is not subject to the contested case procedures in chapter 14. History:  2014 c 311 s 8; 1Sp2017 c 6 art 10 s 126; 1Sp2019 c 9 art 11 s 92; 2021 c 30 art 3 s 36; 1Sp2021 c 7 art 6 s 28